Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bioventures Ltd Novartis currently holds 2,467,961 shares of Akebia Therapeutics, Inc. (AKBA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bioventures Ltd Novartis has been a net seller of AKBA stock. They have purchased $9.6M and sold $12.3M worth of shares.
Bioventures Ltd Novartis's most recent insider trade was on Jun 19, 2020, when they sold 1,001,312 shares at $8.25 per share.
Bioventures Ltd Novartis serves as Executive at Akebia Therapeutics, Inc. (AKBA). They have executed 119 insider transactions totaling $21.9M over their tenure at the company.
Bioventures Ltd Novartis holds the position of Executive at Akebia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Bioventures Ltd Novartis has shown a selling trading pattern, with $9.6M in total purchases and $12.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bioventures Ltd Novartis was on Jun 19, 2020, when they sold $8.3M worth of GRTX shares. This transaction involved 1,001,312 shares at $8.25 per share.
Bioventures Ltd Novartis currently owns 2,467,961 shares of Akebia Therapeutics, Inc. (AKBA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bioventures Ltd Novartis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bioventures Ltd Novartis has 119 Form 4 filings on record as an insider at Akebia Therapeutics, Inc..
Set alerts for Bioventures Ltd Novartis and 40,000+ other insiders.